2022-apr-26 clinical r113336025-ae-131 (hcp, sdy): information was received from multiple sources (healthcare provider, clinical study) regarding a patient who was receiving compounded baclofen, hydromorphone, bupivacaine, and clonidine via an implantable pump for unknown indications for use.It was reported that examination, on (b)(6) 2018, revealed the pump was flipping within the pocket. the patient also reported difficulty activating ptm secondary to the pump flipping. the patient had decreased low back pain relief without being able to activate the ptm.No action taken, as the patient was not ready for surgical revision.On (b)(6) 2018, the patient had persistent difficulty activating the ptm secondary to pump position.No intervention was planned at this visit.The patient was examined, on (b)(6) 2018, and the patient denied difficulty activating the ptm and the pump was filled without any note of pump flipping or inversion.It was indicated the event was related to the device or therapy.The issue resolved without sequelae on (b)(6) 2018.
|